Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by St. Michael's Hospital, Toronto
Sponsor:
Collaborators:
University of California, San Francisco
The Hospital for Sick Children
University of Toronto
Sunnybrook Health Sciences Centre
Ryerson University
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier:
NCT01752049
First received: December 14, 2012
Last updated: October 27, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure)